|
|
The 2nd Anti - Infectives Summit is one of the most prestigious conferences related to the discovery of new drug candidates and antiviral therapeutics. It will facilitate attendees to meet leading experts and key decision makers providing solutions to build and manage effective anti-infective drug portfolio. The conference will enable the attendees to learn how to improve patient outcomes through micro- and nano-medicine. The 2nd Anti-Infectives Summit will bring together heads, directors and executives involved in infectious diseases, clinical pharmacology, drug discovery, molecular biotechnology, scientific affairs and drug development. This is a distinctive opportunity to assess technology platforms which drives nanotechnology and biomimetics. This summit will provide practical solutions to avoid the regulatory issues connected with antiviral cocktails.
Visitor Profile
The targeted visitors at the 2nd Anti - Infectives Summit are VPs, Heads, Directors and Managers of:
- Infectious Diseases
- Microbiology
- Immunology
- Medicinal Chemistry
- Clinical Pharmacology
- Drug Discovery
- New Product Development
- Scientific Affairs
- Licensing
- Antibiotics
- Infection Discovery
- Drug evaluation
- Molecular Biotechnology
- Drug Development
- Project Management
- Preclinical Development
- Portfolio Management
Organizer
IQPC
